Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Orum Therapeutics (475830 KS)
Watchlist
10
Analysis
Health Care
•
South Korea
Orum Therapeutics, Inc. operates as a clinical stage biotech company. The Company develops cell-penetrating antibodies, biomedical therapy applications, and pharmaceuticals for cancer and immune diseases. Orum Therapeutics serves clients worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Philoptics Co Ltd.
•
11 Mar 2025 20:17
Potential KOSDAQ 150 Rebalance Candidates in June 2025
The top 10 inclusion candidates have sharply outperformed KOSDAQ so far this year. These 10 stocks are up on average 75.3% YTD.
Douglas Kim
Follow
903 Views
Share
bearish
•
Hanwha Engine
•
28 Feb 2025 18:52
End of Mandatory Lock-Up Periods for 43 Companies in Korea in March 2025
This insight provide a list of 43 stocks (2 KOSPI and 41 KOSDAQ) with end of mandatory lock-up periods for certain shares in March 2025.
Douglas Kim
Follow
683 Views
Share
bearish
•
Orum Therapeutics
•
03 Jan 2025 20:08
Orum Therapeutics Lowers IPO Price Range
Orum Therapeutics (475830 KS) has lowered its IPO price range to 24,000 won to 30,000 won. The expected market cap of the IPO is between 531...
Douglas Kim
Follow
786 Views
Share
bearish
•
Orum Therapeutics
•
24 Oct 2024 05:55
Orum Therapeutics IPO Valuation Analysis
Our base case target price for Orum Therapeutics is 35,170 won per share, which is within the IPO price range of 30,000 won to 36,000 won per share.
Douglas Kim
Follow
502 Views
Share
bullish
•
Orum Therapeutics
•
08 Oct 2024 21:22
Orum Therapeutics IPO Preview
Orum Therapeutics is getting ready to complete its IPO in KOSDAQ in November 2024.The expected market cap after IPO is from 648 billion won to 778...
Douglas Kim
Follow
750 Views
Share
Previous
1
2
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x